Insulin Human

Insulin human is a 51 residue peptide hormone, composed of two amino acid chains covalently linked by disulfide bonds. The structure is identical to native human insulin. Recombinant insulin is synthesized by recombinant DNA techncology. Inserting the human insulin gene into the Escherichia coli bacteria or Saccharomyces cerevisiae produces insulin for human use. Inhalable insulin is a powdered form of insulin regular, delivered with a nebulizer into the lungs where it is absorbed. Exubera, developed by Inhale Therapeutics (later named Nektar Therapeutics), became the first inhaled insulin product to be marketed in 2006 by Pfizer, but poor sales led Pfizer to withdraw it in 2007. Afrezza, a monomeric inhaled insulin developed by Mannkind, was approved by the FDA in 2014.

Price Not Available 1 mg Insulin Human Supplier Page
Trivial name INS
Catalog Number TP-004CL
Alternative Name(s) Insulin Human
Research Area Endocrine disorders (hormone deficiencies)
Molecular Formula C257H383N65O77S6
CAS# 11061-68-0
Purity >90%
Size 1 mg
Supplier Page https://www.creativebiolabs.net/Insulin-Human-22342.htm
Additional Information Indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 1 and type 2 diabetes mellitus.